{"name":"Schülke & Mayr GmbH","slug":"sch-lke-mayr-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Octenidinedihydrochlorid","genericName":"Octenidinedihydrochlorid","slug":"octenidinedihydrochlorid","indication":"Other","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"octenisept®","genericName":"octenisept®","slug":"octenisept","indication":"Skin antisepsis and disinfection","status":"marketed"}]}],"pipeline":[{"name":"Octenidinedihydrochlorid","genericName":"Octenidinedihydrochlorid","slug":"octenidinedihydrochlorid","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"octenisept®","genericName":"octenisept®","slug":"octenisept","phase":"marketed","mechanism":"Octenisept is an antimicrobial solution that disrupts bacterial and fungal cell membranes through a combination of octenidine and phenoxyethanol, providing rapid broad-spectrum antiseptic activity.","indications":["Skin antisepsis and disinfection","Wound irrigation and cleansing","Oral and pharyngeal antisepsis","Prevention of surgical site infections"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQc055NlNOcVFRRXNaMzB3Yy1YYUF3Uk5Rb2FBaU1SQk51R296SjNBQXFWYXFLM1NFTzVqc281NklKWklReE5SbmJZS2tDMFRxWjQ0OXpIUGJzdTlfdGtqZTVlMWJRR1I0dXNSUTltTmMzODU1eGRBSmRZNlVQR2ZMLVBEeEFZaEZRdVlEQ1NvZzR3WGxwbmhKTtIBngFBVV95cUxOajJ6SHRubnRRd1FiZU1NdVBSWlpoSjFMVlJvZVNmT3pSS1dBOFJMZEdRTmpQR0ZudFd3emNVWTRaSkt5RjN0VGtBZWdyTTBVVC1Fd2lpenNkZEdPNmJydkZWRWFpQUNldDZ2WkVaZFNpSGtGdzB6OUJBY3FyR3hVdTBSNkFyLVdDTkI0clVmWlMyc2U0Qkk1RXd0VWs5dw?oc=5","date":"2025-10-02","type":"pipeline","source":"business-live.co.uk","summary":"North East contamination company Redditch Medical sold to German firm - business-live.co.uk","headline":"North East contamination company Redditch Medical sold to German firm - business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOUzMxMm82MHJibk50dWlvQlRiYlRMY2NtY1VQbEVOVUIzR0VRLUJjZ0hPS1kwN0g5TnpVT0lEOC0tTFdHdkFpZEZkX0RQY0EwOEluVktEem8tVVhUOGw0WFU0MzJMRFd1MkU3djhRNE9PZTZENFB3azVfNDFVSkVkU0xxeUgwTW5VT0pvOTRzOUtfOTRjTXNBWjVjZjVnT094WmVYLUhITTdKRGo3elQ5eTV0X1MwLTNWSjUxVg?oc=5","date":"2023-11-06","type":"pipeline","source":"fortune.com","summary":"Secretive German billionaire twins cut Covid vaccine bet after banking 550% gain - fortune.com","headline":"Secretive German billionaire twins cut Covid vaccine bet after banking 550% gain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNdjVtWWtFQmtCZVVHVlhINktac2lEWEVVVXJRdENvTHlzVDZ1Unk5Q1YtYmtCd3VfMlIzdzdRbE1SYzhhY1Z4M2ItQkM0MERESGxaSGppUFBnQkFRTEEtV2U2VEFJeVNVTjZMdzVwMTdEYzRkV1RyaXdCNm9FZHZfOU5DSWF4YlNpeWJIQlVmSlhkeTlKYm5KUk0tZGpCcnAtYUl6S05hOGphT05CclJqWXAyM2QtZzY1U0RRSUEwck1GMGVPZFdLaGNZdXVnbUhKUFJn?oc=5","date":"2017-01-11","type":"pipeline","source":"Air Liquide","summary":"Air Liquide Japan agreed on joint sales promotion for hand disinfection products - Air Liquide","headline":"Air Liquide Japan agreed on joint sales promotion for hand disinfection products","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}